RoActemra 400 (Tocilizumab Vials) 400mg

RoActemra 400 (Tocilizumab) is an injectable medication used to treat inflammatory conditions like rheumatoid arthritis. This 400mg vial form is designed for subcutaneous or intravenous use under medical supervision. Store between 2-8°C to maintain potency. Always follow healthcare provider instructions.

Strength

400mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Roche

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RoActemra 400 is commonly prescribed to reduce inflammation and joint damage in adults with moderate to severe rheumatoid arthritis. It may also be used for other inflammatory conditions when recommended by a healthcare professional. The medication works by targeting specific pathways in the immune system. Patients often ask what is tocilizumab used for beyond arthritis.

Side Effects

Many patients experience reduced joint pain and swelling after starting RoActemra 400. Some notice improved mobility and daily function over time. Individual responses vary, and effects may take several weeks to become noticeable. Regular monitoring helps track treatment progress.

Precautions & Warnings

Keep RoActemra 400 refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial vigorously. Always check the expiration date before use. Discard any unused portion properly after preparation. Follow your healthcare provider's guidance for safe handling.

Avoid Interactions

RoActemra 400 may interact with other medications that affect the immune system or liver enzymes. Combining it with certain vaccines or live treatments is generally not recommended. Always inform your doctor about all medications you're taking. Alcohol use should be discussed with your healthcare provider.

Frequently Asked Questions

RoActemra 400 is used to treat inflammatory conditions like rheumatoid arthritis by reducing joint damage and inflammation.

Store RoActemra 400 between 2-8°C and protect from light. Do not freeze or shake the vial.

Consult your healthcare provider before using RoActemra 400 during pregnancy or while breastfeeding.

Common effects may include injection site reactions, headache, or upper respiratory infections.

No, RoActemra 400 requires a prescription from a licensed healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.